Tag: marijuana news

PALM BEACH, Fla., July 28, 2021 /PRNewswire/ — Cannabidiol derived from hemp is anticipated to witness rapid growth owing to increasing demand from the pharmaceutical sector and rising awareness among consumers regarding health. Increasing consumer disposable income along with the legalization of medicinal cannabis is anticipated to have a positive impact on the demand for cannabidiol in the pharmaceutical sector. Oils, tinctures, concentrate, capsules, topical solutions such as slaves, lip balms, lotions, and edibles such as baked goods, coffee, chocolates, gums, and candies are some of the CBD products which are in high demand. Due to its healing properties, the demand for cannabidiol (CBD) for health and wellness purposes is high, which is the major factor driving the market growth. In addition, the rising acceptance and use of products due to government approvals is a major factor expected to boost production for CBD-infused products.  A report from Grand View said that the global cannabidiol market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 21.2% from 2021 to 2028.  Active Companies in the merchant industry include Grove, Inc. (NASDAQ: GRVI), Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY), Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED), Pressure BioSciences, Inc. (OTCQB: PBIO), cbdMD, Inc. (NYSE: YCBD).

Grand View added: “Furthermore, the use of hemp-derived CBD is increasing rapidly owing to its anti-inflammatory, anti-aging, and antioxidant properties. Various industries such as pharmaceuticals, personal care and cosmetics, nutraceuticals, and food and beverages are developing CBD-derived products for health and wellness purposes. Therefore, the above-mentioned factors would be responsible for this segment’s fastest growth rate over the forecast period.  The pharmaceutical segment is projected to witness the fastest growth rate over the forecast period. This rapidly progressing transformation of cannabidiol from herbal preparations to prescription drugs is anticipated to boost the growth of the market. Furthermore, growing awareness about the medical benefits of cannabidiol, including its healing properties, is anticipated to drive the product demand in the pharmaceutical industry.”

Grove, Inc. (NASDAQ: GRVI) BREAKING NEWS:  Grove, Inc. Announces Preliminary Fourth Quarter and Fiscal Year 2021 Results Fourth Quarter Revenue Estimated at $10.1-10.4 Million – Grove, Inc. (“Grove” or the “Company”), the Nevada based company redefining the way hemp is bought, produced, and sold today announced preliminary and unaudited financial results for its fourth quarter of fiscal 2021 year ended June 30, 2021.

Preliminary Fourth Quarter Fiscal Year 2021 Highlights

• Revenues of $10.1 million – $10.4 million, an increase of over 300% versus the 4^th quarter of 2020
• Net income of $1.5 – $2 million compared to a loss of over $700,000 in 4^th quarter of 2020

Preliminary Full Fiscal Year 2021 Highlights

• Full year revenues of $23.6 million – $23.9 million, an increase over 200% compared to the $7.4 million in fiscal year 2020
• Net income of $2.0 – $2.5 million compared to a loss of over $5 million in fiscal year 2020

Grove also announced it will release full financial results for fiscal 2021 after the market closes on or before September 15^th, 2021.

Allan Marshall, Chief Executive Officer of Grove, stated, “We are excited to have surpassed all our internal projections for growth and profitability in 2021. The success of our growth is the cumulation of hard work by our entire team and a strategy that built a foundation for continued growth and expansion, while maintaining profitability. I am excited heading into 2022 with some momentum and flexibility to invest in new verticals and continue our internal growth.  With a solid balance sheet and continued positive cash flow from operations, we will look to invest heavily to drive growth in our Products and Manufacturing. We plan for future investments in an Extraction & Lab Facility to pioneer the R&D in the Hemp and Wellness industries for therapeutic and medicinal use”.   For more information about Grove, Inc, please visit https://groveinc.io/investor-relations/.

Other recent developments in the eCommerce/Merchant industry include:

Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, recently announced that its wholly-owned subsidiary in Germany, Aphria RX GmbH, has completed the first successful harvest of medical cannabis cultivated in Germany for distribution to German pharmacies. The medical cannabis harvest is the first cultivated under European Good Manufacturing Practices (EU GMP) standard at Tilray’s state-of-the-art 6,000 square meter indoor growing facility in Neumünster, Germany. The subsequent distribution, which was carried out by a distributor on behalf of the German Cannabis Agency and in accordance with all pharmaceutical and narcotic legal requirements, underscores Tilray’s strong foothold and operational excellence within Europe’s key medical cannabis market.

“Our harvest in Germany represents an important milestone in granting access to high-quality and trustworthy medical cannabis to patients and healthcare professionals in Germany,” said Denise Faltischek, Tilray’s Head of International and Chief Strategy Officer. “It is a testament to the professionalism and dedication of our team that, despite the challenges of a global pandemic, we remained on track as the first licensed producer to cultivate medical cannabis in Germany. Our achievement would not have been possible without the trust and cooperation of the Federal Institute for Drugs and Medical Devices (BfArM) and the Germany Cannabis Agency, for which we are sincerely grateful.”

cbdMD, Inc. (NYSE American: YCBD), one of the leading, and most highly trusted and recognized CBD companies, recently announced that it has entered into a letter of intent to purchase leading CBD online marketplace, DirectCBDOnline.com, from Twenty Two Capital, LLC.

“Owning a CBD online marketplace that sells various CBD brands provides unique transparency to better understand consumer spending habits and trends across the wider CBD and hemp marketplace. In addition, the technology and digital strength that DirectCBDOnline.com owns enhances our overall direct to consumer ecommerce capabilities. We are very excited that the team from DirectCBDOnline.com will be joining cbdMD. John Wiesehan III and Brad Trawick, who are the co-founders of DirectCBDOnline.com will be playing important roles, as we expand further in the global CBD market.

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, recently announced two new offerings with the launch of Tweed Quickies and Ace Valley Pinners. These products showcase the continued evolution of Canopy Growth’s pre-roll portfolio in line with consumer preference – providing Canadians with smaller joints in larger pack sizes of 8 or 10. In time for summer socializing, this is the perfect way to enjoy and share cannabis in a group setting, without having to pass a single joint around.

Canopy Growth recently commissioned a study by Dig Insights that found that traditional 0.5 gram joints are too big for many consumers to enjoy in one sitting and take too long to consume, in addition to concerns around sharing in current times. Canopy Growth leveraged this insight to develop its first two product lines – Tweed Quickies in 0.35 gram and Ace Valley Pinners in 0.3 gram offerings – with research indicating this was the optimal size for a quicker session that could be enjoyed on one’s own or within a group setting without the need to share.

Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, previously announced that its proposed acquisition partner Cannaworx,Inc. set the commercial launch date for its patented immune booster supplement: ImmunaZin™ for Dec 2020. Cannaworx believes that post-launch, this product will be one of very few OTC (over the counter), FDA registered, hemp seed oil-enhanced supplements with an immune booster claim.

The immune system’s role is to keep us healthy by defending against invaders (e.g., bacteria and viruses). It is therefore important to keep our immune systems as strong and effective as possible. Healthy living is the main strategy recommended to achieve this goal. Another strategy is to augment healthy living with powerful, high quality immune boosters, which have recently become very popular, e.g., the global immune booster market is estimated to exceed $25B by 2025 and the market has been spurred further by the on-going COVID-19 pandemic.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult =a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated twenty six hundred dollars for news coverage of the current press releases issued by Grove, Inc. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Media Contact email: editor@financialnewsmedia.com – +1(561)325-8757

View original content:https://www.prnewswire.com/news-releases/global-cannabidiol-market-size-expected-to-reach-2-8-billion-by-2028-with-a-cagr-of-21-301342836.html

SOURCE FinancialNewsMedia.com

source

NEW YORK, July 30, 2021 /PRNewswire/ — Bion Environmental Technologies, Inc. (OTC QB: BNET), a developer of advanced livestock waste treatment technology that dramatically reduces environmental impacts while recovering high-value coproducts, announced that its cannabis trials are starting at Southern Illinois University, using commercial ammonium bicarbonate as a nitrogen fertilizer.

The purpose of the trial is to assess the agronomic performance of commercially available ammonium bicarbonate (AB) as a nitrogen source for cannabis development, compared to a more traditional nitrogen fertilizer. If the results of this trial are positive, as expected, additional trials will be conducted using Bion’s AD Nitrogen (see description below) when it becomes available in sufficient quantities in 2022. The results of subsequent AD Nitrogen trials, if warranted, would be expected to mirror the results demonstrated by the commercial AB product. Planning, design, and preparation for the study will commence this week. The trial will continue through September, followed by lab analysis, with a report expected in February 2022.  

SIU’s School of Agricultural Sciences will conduct the trial for Bion, to determine the effect of ammonium bicarbonate (AB) fertilizer on cannabinoid and terpene development in three different cultivars of the cannabis plant: BAOX, Cherry Citrus, and Super CBD. There will be three experimental treatments: 1) ammonium bicarbonate, 2) standard 12-12-12 fertilizer product, and 3) no additional treatment beyond Scotts Miracle-Gro Osmocote, following transplant like the others, as a control group.  The trial will include 27 plants in total.  Following the pre-determined growth cycle, analysis conducted will include cannabinoids (CBD), tetrahydrocannabinol (THC), and 19 different terpenes, which determine flavor, aroma and other consumer-related characteristics.   

Craig Scott, Bion’s director of communications, stated, “Obviously, with a unique product like AD Nitrogen, we are intrigued by the potential presented by the cannabis fertilizer market, especially the higher-value organic side of it. This is the first step in determining the real potential of that market opportunity as we move forward with trials for several fertilizer applications and product markets we intend to pursue. We are thankful that SIU has the growth trial resources and expertise in cannabis to run this study for us and we hope to be working with them on subsequent trials with our own AD Nitrogen.”

About AD Nitrogen: Bion’s livestock waste treatment technology platform captures, stabilizes, and upcycles the ammonia that normally volatilizes and ‘escapes’ from livestock manure, preventing it from polluting the air and downstream waters. The platform produces AD Nitrogen, comprised of ammonium carbonate and bicarbonate, which is a dry (solid) ‘pure’ nitrogen fertilizer product that is water soluble and readily available to crops. Bion’s liquid ammonium bicarbonate solution was approved for an OMRI Listing by the Organic Materials Review Institute (OMRI) in May 2020, allowing for its use in organic crop production. In May 2021, Bion submitted a new application to OMRI for a listing for AD Nitrogen, which is simply distilled from the previously-approved solution. That application is under review by OMRI.

About Bion: Bion’s patented third generation (3G) technology was designed to substantially reduce the environmental impacts of large-scale livestock production and deliver a USDA-certified sustainable product to the consumer. The platform simultaneously recovers high-value coproducts and renewable energy that increase revenues. Bion’s 3G tech platform can provide a pathway to true economic and environmental sustainability with ‘win-win’ benefits for at least a premium sector of the $200 billion U.S. livestock industry, the environment, and the consumer. For more information, see Bion’s website, www.bionenviro.com. 

This material includes forward-looking statements based on management’s current reasonable business expectations. In this document, the words ‘if’, ‘anticipates’, ‘expected’, ‘will’, ‘potential’, and similar expressions identify certain forward-looking statements. These statements are made in reliance on the Private Securities Litigation Reform Act, Section 27A of the Securities act of 1933, as amended. There are numerous risks and uncertainties that could result in actual results differing materially from expected outcomes.

View original content:https://www.prnewswire.com/news-releases/bion-initiates-cannabis-trials-at-southern-illinois-university-to-evaluate-ammonium-bicarbonate-as-a-nitrogen-fertilizer-301345361.html

SOURCE Bion Environmental Technologies, Inc.

source

PHOENIX, July 30, 2021 /PRNewswire/ – 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”), a vertically integrated, multi-state cannabis operator and retailer, announced the planned stepping down of 4Front Co-Founder and President of Mission Dispensaries Kris Krane, effective immediately, after nearly 11 years of distinguished service with the Company.

The transition of Mr. Krane’s responsibilities in his capacity as president of Mission Dispensaries has been underway for months, and he will continue to serve as a strategic advisor to the Company. 4Front has no immediate plans to fill the president of Mission Dispensaries position and will seek to fill the vacated role at the appropriate time.

4Front’s Chief Executive Officer Leo Gontmakher commented, “Kris has been an invaluable leader not only at our Company and in its formation, success and development, but also in our collective efforts to advance the cannabis industry, the legalization movement and sound regulatory policies. As a frequent speaker at cannabis industry conferences and events around the world, Kris’ work to reform our nation’s misguided drug and marijuana laws, first as the associate director of the National Organization for the Reform of Marijuana Laws (NORML), and then as executive director of Students for Sensible Drug Policy, have helped shape the future of the sector and drug policy reforms for the better. We are grateful for his invaluable contributions to our Company, look forward to working with him in his strategic advisory role, and wish him the best of luck in his future endeavors.”



“In the last 11 years, we went from a few people in a room with an idea, to building a national, vertically integrated cannabis operator with operations and facilities in strategic medical and adult-use cannabis markets, including California, Illinois, Massachusetts, Michigan and Washington,” said Kris Krane, 4Front Co-Founder and Strategic Advisor. “I feel incredibly fortunate to have played an instrumental role in 4Front’s journey to become the premier provider of value-driven, quality cannabis products. More than a decade later, the Company has built a strong reputation for high standards and low-cost cultivation and production methodologies earned through a track record of success in facility design, cultivation, genetics, manufacturing, distribution and retail operations. Most importantly, I am proud of the way we have conducted our business, always staying conscious of the role we play in the broader movement to end cannabis prohibition.”

For more information, visit https://4frontventures.com/ and https://missiondispensaries.com/.

About 4Front Ventures Corp.

4Front Ventures Corp. (“4Front” or the “Company”) (CSE: FFNT) (OTCQX: FFNTF) is a national, vertically integrated multi-state cannabis operator with operations and facilities in strategic medical and adult-use cannabis markets, including California, Illinois, Massachusetts, Michigan and Washington. Since its founding in 2011, 4Front has built a strong reputation for its high standards and low-cost cultivation and production methodologies earned through a track record of success in facility design, cultivation, genetics, growing processes, manufacturing, purchasing, distribution, and retail. To date, 4Front has successfully brought to market more than 20 different cannabis brands and nearly 2,000 unique product lines, which are strategically distributed through its fully owned and operated Mission dispensaries and retail outlets in its core markets. As the Company continues to drive value for its shareholders, its team is applying its decade of expertise in the sector across the cannabis industry value chain and ecosystem. For more information, visit https://4frontventures.com/.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in 4Front Ventures’ periodic filings with securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of 4Front Ventures, statements regarding when or if transactions will close or if/when required conditions to closing are attained, the impact of the transactions on the business of 4Front and other statements regarding future developments of the business. Although 4Front Ventures has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on satisfying closing conditions, [obtaining regulatory approvals]; and engagement in activities currently considered illegal under U.S. federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. 4Front Ventures disclaims any intention or obligation to update or revise such information, except as required by applicable law, and 4Front Ventures does not assume any liability for disclosure relating to any other company mentioned herein.

View original content to download multimedia:https://www.prnewswire.com/news-releases/4front-ventures-corp-announces-updates-to-leadership-team-301345156.html

SOURCE 4Front

source

LOS ANGELES, July 30, 2021 /PRNewswire/ — Eighty Six Brand consistently delivers potent and pure Delta-8 THC-infused products to help you achieve an elevated state of mind nationwide.

 One of the most popular ways to experience Delta-8 THC’s effects is to vape it through a cartridge that is powered by a battery device.  Eighty Six Brand takes the process one step further by adding a touch of convenience to the mix with its all-new Delta-8 THC Disposables collection.

What are Delta-8 THC Disposable Vape Devices?

Delta-8 THC, or tetrahydrocannabinol, is a minor cannabinoid that occurs naturally in hemp.  An analogue of the traditional Delta-9 THC, Delta-8 produces milder psychoactive effects, allowing you to enjoy a manageable high without the attached anxiety or paranoia you’d normally experience after smoking too much, or too fast.

A Delta-8 THC Disposable encloses the rechargeable battery, the one-gram reservoir that holds the Delta-8 distillate, and a coil system to vaporize the distillate all in one convenient device.  Upon depleting the Delta-8, simply throw the entire device away. This eliminates the need to carry multiple components to achieve the same result: an exceptional Delta-8 experience!

Breaking Down the Eighty Six Brand Disposables

The Eighty Six Brand Delta-8 Disposables collection features five of its most popular strains to date.  Between Berry Slush, Boo Berry, Cereal Killer, Grape Soda, and Jen & Berry’s, the offering is reimagined and reformulated by crossing popular strains.  The result retains both its original flavor profile while also supercharging its functional effects.

For those looking for a more mind-altering experience, Boo Berry is a reimagined Blue Dream crossed with Lemon Haze.  Users experience the same great blueberry-dominant taste with added notes of lemon to keep you creative and alert as you tackle the responsibilities of the day.

For those that want to introduce a little more chill into their daily routines, Jen & Berry’s, formerly known as Gelato, sweetens the ice cream party by crossing Ice Cream Cake into the formulation.  Users taste bold vanilla ice cream sandwiched between the classic chocolate cookie crust to mellow out after an otherwise hectic schedule.

Ready to Take the First Step?

While certain states may have specific regulations and laws pertaining to the purchase and consumption of it, Delta-8 THC is federally legal.  If you live in a state where recreational cannabis is illegal, or simply looking for a way to experience a milder and more manageable psychoactive experience, Eighty Six Brand’s all-new Delta-8 THC Disposables collection proves a viable alternative.

View original content to download multimedia:https://www.prnewswire.com/news-releases/eighty-six-brand-delivering-convenience-with-the-delta-8-thc-disposables-collection-301342444.html

SOURCE Eighty Six Brand

source

LOS ANGELES, July 30, 2021 /PRNewswire/ — Eighty Six Brand consistently delivers potent and pure Delta-8 THC-infused products to help you achieve an elevated state of mind nationwide.

 One of the most popular ways to experience Delta-8 THC’s effects is to vape it through a cartridge that is powered by a battery device.  Eighty Six Brand takes the process one step further by adding a touch of convenience to the mix with its all-new Delta-8 THC Disposables collection.

What are Delta-8 THC Disposable Vape Devices?

Delta-8 THC, or tetrahydrocannabinol, is a minor cannabinoid that occurs naturally in hemp.  An analogue of the traditional Delta-9 THC, Delta-8 produces milder psychoactive effects, allowing you to enjoy a manageable high without the attached anxiety or paranoia you’d normally experience after smoking too much, or too fast.

A Delta-8 THC Disposable encloses the rechargeable battery, the one-gram reservoir that holds the Delta-8 distillate, and a coil system to vaporize the distillate all in one convenient device.  Upon depleting the Delta-8, simply throw the entire device away. This eliminates the need to carry multiple components to achieve the same result: an exceptional Delta-8 experience!

Breaking Down the Eighty Six Brand Disposables

The Eighty Six Brand Delta-8 Disposables collection features five of its most popular strains to date.  Between Berry Slush, Boo Berry, Cereal Killer, Grape Soda, and Jen & Berry’s, the offering is reimagined and reformulated by crossing popular strains.  The result retains both its original flavor profile while also supercharging its functional effects.

For those looking for a more mind-altering experience, Boo Berry is a reimagined Blue Dream crossed with Lemon Haze.  Users experience the same great blueberry-dominant taste with added notes of lemon to keep you creative and alert as you tackle the responsibilities of the day.

For those that want to introduce a little more chill into their daily routines, Jen & Berry’s, formerly known as Gelato, sweetens the ice cream party by crossing Ice Cream Cake into the formulation.  Users taste bold vanilla ice cream sandwiched between the classic chocolate cookie crust to mellow out after an otherwise hectic schedule.

Ready to Take the First Step?

While certain states may have specific regulations and laws pertaining to the purchase and consumption of it, Delta-8 THC is federally legal.  If you live in a state where recreational cannabis is illegal, or simply looking for a way to experience a milder and more manageable psychoactive experience, Eighty Six Brand’s all-new Delta-8 THC Disposables collection proves a viable alternative.

View original content to download multimedia:https://www.prnewswire.com/news-releases/eighty-six-brand-delivering-convenience-with-the-delta-8-thc-disposables-collection-301342444.html

SOURCE Eighty Six Brand

source

VANCOUVER, BC, July 30, 2021 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that through its indirect, wholly-owned California subsidiary, the Company has completed the sale of its 9.55 acre land package located in the City of Desert Hot Springs, Riverside County, California (the “DHS property”). Gross consideration for sale was US$1,957,000.

The DHS property was acquired in 2019 as raw land, and over the course of the intervening two years the Company’s development team advanced the land to a shovel-ready state.  Advanced planning, permitting, and engineering work was completed – together with the required anthropological and environmental studies.  In conjunction with the sale, the Company has negotiated a back-in option agreement with the purchaser, such that as the purchaser advances the construction of the project, re-named “AMP Industrial Park”, the Company has the unilateral option to acquire a new 16,460 square-foot cannabis production and processing building at a predetermined price.

Chemistree president Karl Kottmeier commented, “The property was sold at a significant profit to the Company. We purchased the DHS property prior to a dramatic downturn in the cannabis market and found, despite the excellent development work by our California team led by our Chief Cannabis Officer Sheldon Aberman, that the project had become essentially un-financeable given the drastic increase in the cost of capex and opex capital. We persevered with the development plan, held the project in good standing throughout and have now turned a profit from this investment. This is an important capital infusion for the Company and will allow management and the Board of Directors to better plan for future investments.”

About Chemistree Technology Inc.

Chemistree Technology Inc. is an investment company with holdings in the U.S. cannabis sector, real estate, and a consumer-targeted biotechnology venture.  The Company’s corporate strategy is to focus on opportunistic investments across a broad range of industries, and is seeking to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services, mentoring and access to the Company’s management expertise. For more information, visit www.Chemistree.ca  

Advisory

The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

The concepts of “medical cannabis” and “recreational cannabis” do not exist under U.S. federal law. The Federal Controlled Substances Act classifies “marihuana” as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defence to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the Prospectus, the Company’s annual information form and other documents incorporated by reference therein and in the Company’s Form 2A listing statement filed with the CSE and available under the Company’s profile on SEDAR at www.sedar.com.

“Karl Kottmeier” 

President 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Information set forth in this news release includes forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, “budget”, “scheduled” and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the Company’s reports and filings with the applicable Canadian securities regulators. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/chemistree-sells-desert-hot-springs-development-property-301345084.html

SOURCE Chemistree Technology Inc.

source

TEL AVIV, Israel and BIELEFELD, Germany, July 29, 2021 /PRNewswire/ — Panaxia Labs Israel Ltd. (“Panaxia Israel”), (TASE: PNAX), a global pharma company, specializes in developing, manufacturing and marketing progressive medical cannabis products in pharmaceutical quality and the German pharmaceutical company AxioNovo GmbH, specialized in the field of Oncology, announced today the signing of an agreement. The agreement, a part of Panaxia’s collaboration with Neuraxpharm, is for the marketing, sale and distribution of a new series of medical cannabis products, with a unique formulation, designed and being used in Israel for oncology patients. These formulations will be distributed in Germany as pharmaceutical intermediates for magistral preparations.

 Dr. Dadi Segal, CEO of Panaxia Israel: “We welcome the agreement with AxioNovo GmbH and we are proud of this vote of confidence from a specialized German pharma company in the field of Oncology, which has chosen Panaxia as a strategic partner to make advanced and innovative medical cannabis-based treatments accessible to patients all over Germany, as well as our collaboration with Neuraxpharm on CNS. This is a significant step in recognizing our contribution and fulfilling our potential within the largest market in Europe“.

Udo Wieners, CEO of AxioNovo GmbH:” As part of PharmaMed Group, we offer various services and products in the field of oncology in Germany. We look forward to launching the Naxiva Panaxol Onko product line in partnership with Panaxia as a part of our already existing portfolio for cancer patients and believe that this is an excellent extension of our holistic approach to treatment.”

The agreement was signed for 5 years, during which Panaxia will be responsible for manufacturing the products under the European standard (EU-GMP), and their registration according to regulatory requirements in Germany. AxioNovo GmbH will be in charge of marketing, sale and distribution of medical cannabis-based products by Panaxia to cancer patients through direct purchase in pharmacies, following prescriptions from oncologists at cancer specialized clinics in Germany. These products are designed and currently being used in Israel for various medical indications, such as Cancer Pain, Loss of appetite and other side effects, related to Cancer treatments.  

The new series of products, under the brand Naxiva Panaxol Onko, is characterized by designated formulations and new extracts adapted for oncology patients in Israel. The products were developed based on extensive clinical data accumulated in Panaxia for over a decade and its comprehensive experience in treating cancer patients in Israel. First sales of the products in Germany are expected in the 3^rd quarter of 2021, subject to obtaining a regulatory approval from the German authorities for marketing and distribution of the products.

This collaboration is in addition to Panaxia’s collaboration in Germany with Neuraxpharm in the field of traditional CNS, regarding marketing Panaxia’s products to patients since early 2021.

About AxioNovo GmbH

AxioNovo GmbH, a member of PharmaMed Group, is a modern pharmaceutical company based in Bielefeld, Germany, focusing on Oncology, with a clear vision, innovative concepts, progressive approach and a unique organizational culture. For over 15 years, AxioNovo GmbH has been focusing on the most important value – Health, specializing in the treatment and cure of diseases and providing relief to patients by advanced, high-quality and cost-effective oncology medicines. AxioNovo GmbH is committed to the principles of the FSA Code (Code of Transparency of the German Association for Voluntary Self-Regulation in the Pharmaceutical Industry) and thus regards social responsibility as a matter of course.

About Panaxia Labs Israel

Panaxia Labs Israel, Ltd. is a publicly traded company at TASE (TASE: PNAX). It is a global pharma company, that develops, manufactures, and markets advanced medical cannabis products of pharmaceutical high quality. Panaxia, the pioneer and largest medical cannabis manufacturer in Israel, is the only company in Israel with an EU-GMP approved factory from the European Health Authority, which is required for the commercial production and export of medical cannabis and its products to Europe. Panaxia specializes in the development, production, and marketing of complex and advanced cannabis plant products, based on clinical information and a broad database of tens of thousands of patients.

Panaxia Israel is a subsidiary of the Panaxia Pharmaceutical Industries, established in 2010 by Dr. Dadi Segal (PhD), Dr. Eran Goldberg (PhD) and Assi Rotbart (LL. B), as the cannabis division of Segal Pharma Group, operating for over four decades, producing more than 600 different pharmaceutical products distributed in over 40 countries.

The Panaxia Group has over 150 employees.

Panaxia website: https://panaxia.co.il/

AxioNovo GmbH: https://www.axionovo.net/

For further information, please contact:

yelena@panaxia.co.il

View original content:https://www.prnewswire.com/news-releases/panaxia–axionovo-gmbh-will-market-cannabis-based-products-in-germany-301344246.html

SOURCE Panaxia Pharmaceutical Industries

source

 HGS Hydro to Join GrowGen’s Portfolio, Expands Company’s Footprint in Michigan

DENVER, July 28, 2021 /PRNewswire/ — GrowGeneration Corp. (NASDAQ: GRWG), (“GrowGen” or the “Company”) the nation’s largest chain of specialty hydroponic and organic garden centers, today announced the signing of an asset purchase agreement to acquire HGS Hydro, the nation’s third-largest chain of hydroponic garden centers, with six stores across Michigan and a seventh store slated to open in the fall of 2021. This transaction is expected to close before the end of fiscal year-end 2021. Founded in 2015 by Rocky Shaeena, HGS Hydro is the largest chain of hydroponic garden centers in the state of Michigan and generated approximately $50 million in revenue in 2020.

When completed, the transaction will also bring the total number of GrowGen hydroponic garden centers in Michigan to 14 and the total number of stores to 65. The new GrowGen locations will include Shelby Township, Southfield, Sterling Heights, Hazel Park, Walled Lake, Albion, and Imlay City, Michigan.

“We are excited to add HGS Hydro to our portfolio of stores before year end, with its impressive leadership and commercial teams. The addition of HGS Hydro will propel Michigan to GrowGen’s second largest state behind California.  Michigan is one of the fastest growing states for medical and recreational cannabis sales.” said Darren Lampert, GrowGen’s CEO. “We look forward to building on HGS Hydro’s experience as we continue to expand our commercial footprint. This acquisition represents our continued focus on purchasing ‘best of breed’ hydroponic operations in the U.S. and strengthening our management team with seasoned veterans from our industry.”

“The combination of HGS Hydro and GrowGeneration will further solidify GrowGen’s leadership position as the nation’s largest chain of hydroponic garden centers. As one of the pioneers of our industry, we are excited to bring our years of experience, insight, and relationships to the GrowGen team to assist in the Company’s continued growth and success,” said HGS Hydro’s CEO Rocky Shaeena. 

“At HGS Hydro, my biggest priority has always been serving our loyal customers and providing an abundance of inventory at all times.  We have grown tremendously as a company in the past, and I believe merging with GrowGeneration will help us continue to grow with the best service and selection possible for our customers.” said Chris Kiryakoza, HGS Hydro’s COO.

About GrowGeneration Corp:

GrowGen owns and operates specialty retail hydroponic and organic gardening centers. Currently, GrowGen has 58 stores, which include 21 locations in California, 8 locations in Colorado, 7 locations in Michigan, 5 locations in Maine, 5 locations in Oklahoma, 2 locations in Nevada, 2 locations in Washington, 4 locations in Oregon, 1 location in Arizona, 1 location in Rhode Island,1 location in Florida, and 1 location in Massachusetts. GrowGen also operates an online superstore for cultivators at growgeneration.com and B2B ERP platform, agron.io. GrowGen carries and sells thousands of products, including organic nutrients and soils, advanced lighting technology and state of the art hydroponic equipment to be used indoors and outdoors by commercial and home growers.

Forward Looking Statements:

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect opinions only as of the date of this release. Please keep in mind that the company does not have an obligation to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as “look forward,” “believe,” “continue,” “building,” or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by us herein are often discussed in filings made with the United States Securities and Exchange Commission, available at: www.sec.gov, and on the company’s website, at: www.growgeneration.com.

Company Inquiries:

GrowGeneration Corp.

610-216-0057

michael@growgeneration.com

Investor Contact:

John Evans

GrowGeneration

john.evans@growgeneration.com

415-309-0230

Connect:

Website: www.GrowGeneration.com

Instagram: growgen

Facebook: GrowGenerationCorp

Twitter: @GrowGenCorp

View original content to download multimedia:https://www.prnewswire.com/news-releases/growgeneration-signs-asset-purchase-agreement-to-acquire-nations-third-largest-chain-of-hydroponic-garden-centers-301343127.html

SOURCE GrowGeneration

source

NEW YORK, July 27, 2021 /PRNewswire/ —

BizVibe has made available 100+ company profiles for the hemp product manufacturers and suppliers category on its B2B platform. Companies listed in this product category are primarily engaged in manufacturing or supplying various types of hemp products (such as hemp oil, hemp clothing, hemp plastic, etc.). Companies which provide various hemp-related services (such as hemp drying and processing) are also included in the category.

Get Free Access to These 100+ Profiles

Each profile is free to view and packed with high-quality insights, providing businesses with detailed company information. Users can take advantage of these insights to identify, target, and connect with the right hemp product manufacturers and suppliers. This company information includes employee insights, company competitors, the impact of emerging trends and challenges, the latest news, and more.

Free Insights Included for all Hemp Product Manufacturer and Supplier Profiles:

• List of product and service category offerings and primary operating industries
• Risk of doing business score across four different metrics
• List of key executives and their roles within the company
• Company financials and general organizational information
• Global, national, and regional competitors
• List of key clients
• Top trends and challenges within operating industry and expected influence on business impact
• Latest company news with the ability to sign up for timely news alerts

Get Started to View Free Company Insights

Hemp Companies on BizVibe

BizVibe’s platform contains 10M+ company profiles, spanning across 200+ countries, categorized into 40,000+ products and services. There are 100+ company profiles related to hemp product manufacturers and suppliers on BizVibe, covering 15+ product and service categories. Each company profile contains detailed insights dedicated to helping procurement and sales teams find trusted suppliers and target sales prospects.

Examples of hemp product manufacturer, supplier, and service provider company profiles that can be discovered on BizVibe include:

• Hemp clothing manufacturers
• Hemp oil manufacturers
• Hemp fiber manufacturers
• Hemp plastic manufacturers
• Hemp drying manufacturers
• Hemp processing manufacturers

Get Free Company Profile Access for all Categories

Company Profiles for Buyers and Sellers

BizVibe’s modern B2B platform is designed to help both global buyers and sellers. Powered by the latest best-in-class solutions, BizVibe provides outstanding product features for both category managers and sales professionals.

Features for Buyers:

• Quickly discover the right suppliers
• Create short lists and custom alerts
• Mitigate supplier risk and evaluate suppliers
• Send RFIs/RFPs

Learn how BizVibe helps buyers: https://www.bizvibe.com/find-suppliers

Features for Sellers:

• Target the right sales prospects
• Qualify leads
• Analyze buyer potential
• API integration and data enrichment

Learn how BizVibe helps sellers: https://www.bizvibe.com/sellers

About BizVibe

BizVibe has been conceptualized and built by a team based out of Toronto, Bangalore, and London. We are a branch of Infiniti Research and have dedicated units in all three locations. BizVibe helps buyers find the most relevant suppliers from around the world and help sellers target prospects who need their products and/or services. For more information, please visit www.bizvibe.com and start for free today.

Contact

BizVibe

Jesse Maida

Email: jesse@bizvibe.com

+1 855-897-5880

Website: https://www.bizvibe.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/evaluate-and-track-hemp-companies–view-company-insights-for-100-hemp-product-manufacturers-and-suppliers–bizvibe-301339778.html

SOURCE BizVibe

source

LOS ANGELES, July 29, 2021 /PRNewswire/ — Viola, the leading and only Black-owned multinational cannabis operator rooted in building equity within the space, today officially announces its partnership with NBA Legend Allen Iverson. The icon and people’s champ enters into a multi-year partnership that spans cannabis, product, and merchandise with Viola, co-founded by CEO Al Harrington, to create an industry leading and scalable collaboration across product lines and markets.

Iverson joined Al in Viola’s 18,000 sq ft Detroit grow in March, getting an in depth tour of the growing process from Viola’s head grower and Al Harrington himself. Upon seeing the full-scale operation, the true dedication to the plant, along with Viola’s unwavering commitment to increasing minority participation and ownership in the cannabis industry (currently at only 4%), Allen was sure this partnership was meant to be.

“I’ve had a lot of people approach me with business opportunities, but this one with Al was different,” said Iverson. “After seeing how devoted he is to this business, and him educating me on how beneficial the plant is, it just felt right. I’m excited to be a part of it. Together, we’re about to change the game.”

The partnership will feature a variety of cannabis and non-cannabis products, including The Iverson Collection, a series of strains that will launch across the markets in which Viola operates. The first strain will launch in California this October exclusively at Elevate and Jade Room.

“In the same way Allen impacted the culture, we’re going to continue to impact the cannabis industry,” said Viola CEO, Al Harrington. “We’re going to keep pushing boundaries. I’m honored to have Allen on board. We want to continue to inspire others and encourage people of color to participate in the cannabis space.”

In addition to the Viola partnership, Allen is also partnering with Harrington on his wellness CBD brand rePlay with future announcements forthcoming under the Harrington Wellness umbrella.

About Viola:

Viola is the leading Black-owned producer and licensed wholesaler of premium cannabis products rooted in purpose. Founded in 2011, NBA veteran Al Harrington was inspired to launch the brand by his grandmother, Viola, who suffers from glaucoma and diabetes and found solace in cannabis remedies. The brand integrates the latest cutting-edge technology with its own proprietary processes designed for every stage of cultivation, extraction and production. Viola is known for its wide variety of product offerings, from high-quality flower to premier butane extracts. From regulation to representation and reform, Viola’s mission is to create opportunities for communities of color in the cannabis industry.

View original content to download multimedia:https://www.prnewswire.com/news-releases/allen-iverson-enters-multi-year-partnership-with-viola-brands-301344185.html

SOURCE Viola

source